Pubdate: Mon, 05 Dec 2005
Source: Boston Globe (MA)
Copyright: 2005 Globe Newspaper Company
Contact:  http://www.boston.com/globe/
Details: http://www.mapinc.org/media/52
Author: Scott Allen, Globe Staff
Bookmark: http://www.mapinc.org/find?232 (Chronic Pain)
Bookmark: http://www.mapinc.org/oxycontin.htm (Oxycontin/Oxycodone)

DOCTOR'S CASE HIGHLIGHTS GAP IN DRUG SYSTEM

Before Arrest, He Led State In OxyContin Prescriptions

By the time Dr. Michael Brown was arrested in August in a Jaguar that 
police say was loaded with cash, prescription drugs, and a jumble of 
patient records, his reputation for liberally dispensing painkillers 
had earned him a nickname in law enforcement circles: Dr. Feel Good.

Police had identified at least eight suspected drug addicts or 
dealers among Brown's patients, according to a state investigator's 
report, and a mothers' group had picketed his Cape Cod office last 
summer, accusing him of addicting young people to the highly potent 
drug OxyContin.

Yet, the state office that tracks doctors' prescriptions of highly 
addictive drugs did not notify police or medical regulators while 
Brown, for more than a year before his arrest, was emerging as the 
single biggest prescriber of OxyContin in Massachusetts. The 
Prescription Monitoring Program's records show that Brown, an 
internist working alone in Sandwich, prescribed about 1.7 percent of 
the OxyContin prescribed in the state in 2004. The 144,435 tablets of 
the narcotic he prescribed in the first six months of this year led 
the state's doctors by a wide margin.

Though monitors collect information on more than 2 million 
prescriptions for addictive drugs each year, they rarely release 
information about individual doctors unless police or regulators 
request it -- and then only if a panel of doctors and pharmacists 
agrees that release of information will not unfairly raise suspicions.

Nancy Achin Audesse, director of the Board of Registration in 
Medicine, said senior staff in the physician-licensing agency can't 
recall ever receiving a tip about potential overprescribing by a 
doctor from the Drug Monitoring Program. "The correct way to identify 
an allegedly misprescribing doctor is not by mothers walking outside 
the doors," she said, adding that state agencies "need to do a better 
job of sharing information."

Brown has pleaded not guilty to one count of illegal possession with 
intent to sell the painkiller Norco and 12 counts of illegal drug 
possession. The drugs in his car -- mostly medicines for asthma, 
allergies, and erectile dysfunction -- were merely sample packs that 
drug companies supply to physicians, he has said. His lawyer Russell 
Redgate denied that Brown improperly prescribed or sold narcotics, 
saying critics such as the protesters at his office last summer are 
spreading baseless rumors.

Brown's license to practice medicine was suspended within three days 
of his arrest, but the cochairman of the Legislature's OxyContin 
Commission, Representative Peter Koutoujian, believes the board could 
have acted much earlier if it had been notified of Brown's OxyContin 
prescribing pattern.

Koutoujian, a Watertown Democrat, believes the case shows how 
Massachusetts is falling behind in the battle against one of the 
fastest-growing kinds of drug abuse: More than 9 million Americans 
take prescription drugs for nonmedical purposes, sometimes with fatal 
results. Other states have created readily accessible databases that 
allow law enforcement officials and licensing agencies to quickly 
check doctors' prescribing habits and find drug-addicted patients who 
"doctor shop" by approaching multiple doctors for narcotics.

"When the drug monitoring program started in 1992, it was one of the 
first in the nation and ahead of its time . . . but other states have 
caught up and surpassed Massachusetts," said Koutoujian. He said his 
panel is expected to recommend that investigators and regulators get 
greater access to prescribing records of physicians when it reports 
early next year on prescription drug abuse.

Doctors who support the current monitoring program say the state 
needs to be cautious about releasing prescribing information to 
investigators because dispensing large volumes of narcotics, by 
itself, is a poor indicator that doctors are doing anything wrong. 
Doctors who run pain management clinics, they point out, would 
normally prescribe many pain relievers, and over-zealous 
investigators could discourage them from adequately treating their patients.

"If there are 100 doctors in Massachusetts all prescribing over some 
number of OxyContin dosages, there's no evidence those physicians are 
any more likely to be" overprescribing drugs than other doctors, said 
Paul Dreyer, director of the division of health care quality in the 
Department of Public Health, which runs the monitoring program.

Brown's prescribing of pain relievers first came to the attention of 
law enforcement officials in the mid-1990s, but they had difficulty 
accumulating enough evidence to charge him with a crime.

The Board of Registration, meanwhile, received at least two 
complaints alleging Brown knowingly prescribed painkillers for drug 
addicts in the late 1990s, according to board records. One patient 
wrote in 1999 that "Dr. Brown is known among a whole realm of people 
and friends for prescribing [narcotics] . . . to satisfy our 
addiction." But, in each case, the complaint came from a drug addict 
and Brown denied the accusations. Unable to resolve the contradictory 
versions, the board entered documents in Brown's file to note the 
charges had been made.

Redgate said the history of fruitless investigations only proves his 
client is not a drug trafficker. "I've seen in print that the [Drug 
Enforcement Administration] has been investigating Dr. Brown for 10 
years. If true, that's a sterling recommendation" for Brown's 
innocence, said Redgate. Brown is free with no bail, he said.

But members of a family support group called Learn2Cope said that 
Brown's name came up repeatedly at meetings as the doctor who 
prescribed narcotics to addicted family members. Marilyn, who asked 
that her last name not be used to protect her 23-year-old son's 
identity, said he repeatedly went to Brown when the son became 
addicted to painkillers following nose surgery. "He along with many 
of his addict friends would frequent Dr. Brown's office and would pay 
between $120 and $150 cash for an OxyContin prescription" that her 
son would then fill at a drugstore, she said. However, she never went 
to police with her accusation.

Earlier this year, a pharmacist on Cape Cod told an investigator from 
the Board of Registration that she had been suspicious of Brown's 
practices for eight years, noting that his patients tended to stay on 
the same dose of OxyContin with no sign Brown was trying to wean them 
off the medicine, according to a board investigator's report on Brown.

Board officials, for reasons that haven't been made public, asked the 
drug monitors for information on Brown in mid-2003, but, at the time, 
Brown did not rank among the top 100 prescribers of OxyContin. 
However, that soon changed as Brown began "ramping up" his 
prescriptions of narcotics including OxyContin, according to Dreyer. 
By 2004, Brown was in the top 10 of OxyContin prescribers, and he 
ranked number one for the first half of 2005, Dreyer said.

He confirmed that the drug monitors didn't alert the Board of 
Registration or police to the trend, but he felt they did not need to 
because the board had already asked about Brown once in the past. "If 
they want to know more about him, they can ask us," he said.

During the investigation, an informant allowed police to videotape 
Brown as the doctor repurchased a bag of the narcotic Norco that he 
had originally prescribed to the informant. The informant told police 
that Brown regularly prescribed drugs for him and then bought them back.

On Aug. 22, police arrested Brown in his car. They found 12 different 
prescription drugs, more than $60,000 in cash, and X-rays and MRIs in 
the trunk. Three days later, his medical license was suspended, but 
by then, board documents show, grave questions about Brown's medical 
practice were surfacing: In the fall of 2004, he allegedly diagnosed 
one elderly woman's lung cancer as a rib injury that required pain 
relievers, rejecting her daughter's suggestion of a second opinion. 
"Specialist, schmecialist," Brown told the daughter, according to a 
report by the Board of Registration.

Peter Sundelin, another attorney for Brown, said the report contains 
"substantial inaccuracies," though he declined to elaborate.

Koutoujian, of the OxyContin Commission, said the case underscores 
the need to modernize the drug monitoring program along the lines of 
other states.

In Kentucky, which allows authorized people to directly access its 
computerized drug-monitoring program, doctors are among its main 
supporters, say program officials. Robert Benvenuti, inspector 
general of the Kentucky Cabinet for Health and Family Services, said 
85 percent of system users are doctors, mainly checking on their 
patients' prescription history to keep from falling prey to 
doctor-shoppers. The system, nicknamed KASPER, also saves 
investigators time they once spent calling individual drug stores, 
reducing the average duration of doctor-shopping investigations from 
156 days to 16.

But Kentucky's system isn't cheap. The state spent $1.4 million to 
create the computer network, and a dozen employees spend at least 
part of their time working with KASPER. Massachusetts, by contrast, 
has only one employee who works primarily on prescription monitoring, 
and he has other duties as well. Dreyer said the state hopes to add 
software next year that will allow officials to track "doctor 
shopping" patients.

"When the drug monitoring program started in 1992, it was one of the 
first in the nation and ahead of its time . . . but other states have 
caught up and surpassed Massachusetts," said Koutoujian. He said his 
panel is expected to recommend that investigators and regulators get 
greater access to prescribing records of physicians when it reports 
early next year on prescription drug abuse.

Doctors who support the current monitoring program say the state 
needs to be cautious about releasing prescribing information to 
investigators because dispensing large volumes of narcotics, by 
itself, is a poor indicator that doctors are doing anything wrong. 
Doctors who run pain management clinics, they point out, would 
normally prescribe many pain relievers, and over-zealous 
investigators could discourage them from adequately treating their patients.

"If there are 100 doctors in Massachusetts all prescribing over some 
number of OxyContin dosages, there's no evidence those physicians are 
any more likely to be" overprescribing drugs than other doctors, said 
Paul Dreyer, director of the division of health care quality in the 
Department of Public Health, which runs the monitoring program.

Brown's prescribing of pain relievers first came to the attention of 
law enforcement officials in the mid-1990s, but they had difficulty 
accumulating enough evidence to charge him with a crime.

The Board of Registration, meanwhile, received at least two 
complaints alleging Brown knowingly prescribed painkillers for drug 
addicts in the late 1990s, according to board records. One patient 
wrote in 1999 that "Dr. Brown is known among a whole realm of people 
and friends for prescribing [narcotics] . . . to satisfy our 
addiction." But, in each case, the complaint came from a drug addict 
and Brown denied the accusations. Unable to resolve the contradictory 
versions, the board entered documents in Brown's file to note the 
charges had been made.

Redgate said the history of fruitless investigations only proves his 
client is not a drug trafficker. "I've seen in print that the [Drug 
Enforcement Administration] has been investigating Dr. Brown for 10 
years. If true, that's a sterling recommendation" for Brown's 
innocence, said Redgate. Brown is free with no bail, he said.

But members of a family support group called Learn2Cope said that 
Brown's name came up repeatedly at meetings as the doctor who 
prescribed narcotics to addicted family members. Marilyn, who asked 
that her last name not be used to protect her 23-year-old son's 
identity, said he repeatedly went to Brown when the son became 
addicted to painkillers following nose surgery. "He along with many 
of his addict friends would frequent Dr. Brown's office and would pay 
between $120 and $150 cash for an OxyContin prescription" that her 
son would then fill at a drugstore, she said. However, she never went 
to police with her accusation.

Earlier this year, a pharmacist on Cape Cod told an investigator from 
the Board of Registration that she had been suspicious of Brown's 
practices for eight years, noting that his patients tended to stay on 
the same dose of OxyContin with no sign Brown was trying to wean them 
off the medicine, according to a board investigator's report on Brown.

Board officials, for reasons that haven't been made public, asked the 
drug monitors for information on Brown in mid-2003, but, at the time, 
Brown did not rank among the top 100 prescribers of OxyContin. 
However, that soon changed as Brown began "ramping up" his 
prescriptions of narcotics including OxyContin, according to Dreyer. 
By 2004, Brown was in the top 10 of OxyContin prescribers, and he 
ranked number one for the first half of 2005, Dreyer said.

He confirmed that the drug monitors didn't alert the Board of 
Registration or police to the trend, but he felt they did not need to 
because the board had already asked about Brown once in the past. "If 
they want to know more about him, they can ask us," he said.

During the investigation, an informant allowed police to videotape 
Brown as the doctor repurchased a bag of the narcotic Norco that he 
had originally prescribed to the informant. The informant told police 
that Brown regularly prescribed drugs for him and then bought them back.

On Aug. 22, police arrested Brown in his car. They found 12 different 
prescription drugs, more than $60,000 in cash, and X-rays and MRIs in 
the trunk. Three days later, his medical license was suspended, but 
by then, board documents show, grave questions about Brown's medical 
practice were surfacing: In the fall of 2004, he allegedly diagnosed 
one elderly woman's lung cancer as a rib injury that required pain 
relievers, rejecting her daughter's suggestion of a second opinion. 
"Specialist, schmecialist," Brown told the daughter, according to a 
report by the Board of Registration.

Peter Sundelin, another attorney for Brown, said the report contains 
"substantial inaccuracies," though he declined to elaborate.

Koutoujian, of the OxyContin Commission, said the case underscores 
the need to modernize the drug monitoring program along the lines of 
other states.

In Kentucky, which allows authorized people to directly access its 
computerized drug-monitoring program, doctors are among its main 
supporters, say program officials. Robert Benvenuti, inspector 
general of the Kentucky Cabinet for Health and Family Services, said 
85 percent of system users are doctors, mainly checking on their 
patients' prescription history to keep from falling prey to 
doctor-shoppers. The system, nicknamed KASPER, also saves 
investigators time they once spent calling individual drug stores, 
reducing the average duration of doctor-shopping investigations from 
156 days to 16.

But Kentucky's system isn't cheap. The state spent $1.4 million to 
create the computer network, and a dozen employees spend at least 
part of their time working with KASPER. Massachusetts, by contrast, 
has only one employee who works primarily on prescription monitoring, 
and he has other duties as well. Dreyer said the state hopes to add 
software next year that will allow officials to track "doctor 
shopping" patients. 
- ---
MAP posted-by: Beth Wehrman